David A. Andry | Senior Director National Accounts

David Andry, Senior Director National Accounts

David A. Andry, OTR/L graduated from Florida International University in 1993 with his Bachelor’s Degree in Occupational Therapy. Since 1993, David has  worked as an occupational therapist in various areas including in-patient and out-patient rehab, long term care, acute care settings, home health and wound care. In addition, throughout his career as an occupational therapist, he has always worked in pediatrics as well and has specialized in this area. He continues to devote his time to working with children on weekends.

David has also worked in extensively in the pharmaceutical arena from sourcing products, product development, and unit dose solutions for hospitals via in-house repackaging and sales.

David brings his vast clinical knowledge and sales edge to provide quality, customer oriented service; not only to his customers, but also the patients, pharmacies, and physicians they serve.

Companies Worked For:

  • Parkway Regional Medical Center-Miami, Fl
  • Mercy Hospital-Miami, Fl
  • Hearing and Speech Center of Florida-Miami, Fl
  • Theracare Home Health-Miami, Fl
  • Quali-Care Home Health-Miami, Fl
  • Florida Homebound, Miami, Fl
  • Handwriting Without Tears, Cabin John, MD-Based in Miami
  • Abilities in Motion-Miami, Fl Owner private therapy company servicing schools in migrant farmworkers communities and homebound children.
  • AHP Group, Miami, Fl
  • Gensco Pharma, Miami, Fl-Based in Las Vegas, NV

Return to Gensco Leadership Team Page »

Gensco Executive Team

Paul Zimmerman, M.D. | Chairman & CEO   bio »

Frank Aguilar | VP, National Accounts

Crystal Lore | VP, Business Development   bio »

Robert L. Wilbur, Pharm.D., CPh | Executive Director, Medical Affairs   bio »

David A. Andry | Senior Director National Accounts

Lewis Archibeck | Sr. Sales Executive

Lisa Capote, Esq | General Counsel

Return to Gensco Leadership Team Page »


Gensco® Pharma Announces RizaFilm® Commercialization Update in the United States September 26, 2023 Featured, Industry, Press Release, Product Update - Gensco® Pharma, a specialty pharmaceutical company, in partnership with IntelGenx is announcing the anticipated launch of RizaFilm® for Q1-2024. RizaFilm®… more...

Looking To The Future



A single dose topical colchinium for acute gout flares.

See all news